Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bin N. Zhao
Observed names:
B Zhao,
B. N. Zhao,
B. Zhao,
Bin N Zhao,
Bin Zhao
Institution:
ChemoCentryx (United States)
Observed institutions:
National Institutes of Health,
Harbin Medical University,
University of Münster,
National Heart, Lung, and Blood Institute,
ChemoCentryx (United States),
Virginia Commonwealth University Medical Center,
Ruhr University Bochum
show all 7
ORCID:
0000-0001-7828-1605
Observed ORCID:
0000-0001-7828-1605
OpenAlex ID:
A5101852012
CXCR4 over-expression and survival in cancer: A system review and meta-analysis
2014
·
Hongli Zhao
, Liyuan Guo
, et al.
·
Oncotarget
·
275
PDF
Heterogeneity of Human Macrophages in Culture and in Atherosclerotic Plaques
2008
·
Stephen W. Waldo
, Yifu Li
, et al.
·
American Journal Of Pathology
·
250
PDF
Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease
2010
·
Matthew J. Walters
, Yu Wang
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
157
CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice
2013
·
Timothy Sullivan
, Zhenhua Miao
, et al.
·
American Journal of Physiology-Renal Physiology
·
88
Constitutive Receptor-independent Low Density Lipoprotein Uptake and Cholesterol Accumulation by Macrophages Differentiated from Human Monocytes with Macrophage-Colony-stimulating Factor (M-CSF)
2006
·
Bin Zhao
, Yifu Li
, et al.
·
Journal of Biological Chemistry
·
80
Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes
2013
·
Timothy J. Sullivan
, Zhenhua Miao
, et al.
·
Metabolism
·
51
CCR2-Mediated Uptake of Constitutively Produced CCL2: A Mechanism for Regulating Chemokine Levels in the Blood
2019
·
Bin N Zhao
, James J Campbell
, et al.
·
The Journal of Immunology
·
29
PDF
Identification of a novel intracellular cholesteryl ester hydrolase (carboxylesterase 3) in human macrophages: compensatory increase in its expression after carboxylesterase 1 silencing
2012
·
Bin Zhao
, Jinghua Bie
, et al.
·
American Journal of Physiology-Cell Physiology
·
26
CCR2 antagonism leads to marked reduction in proteinuria and glomerular injury in murine models of focal segmental glomerulosclerosis (FSGS)
2018
·
Zhenhua Miao
, Linda S. Ertl
, et al.
·
PLoS ONE
·
15
PDF
Endothelial cells injured by oxidized low density lipoprotein
1995
·
B. Zhao
, Y. Zhang
, et al.
·
American Journal of Hematology
·
15
Influence of low density lipoproteins on cytosolic free Ca2+ concentration and dense tubular system in human platelets
1993
·
B. Zhao
, R. Dierichs
, et al.
·
Thrombosis Research
·
14
Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complications
2012
·
T. J. Sullivan
, D. J. Dairaghi
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
11
Oxidized LDL damages endothelial cell monolayer and promotes thrombocyte adhesion
1998
·
B. Liu
, A. Sidiropoulos
, et al.
·
American Journal of Hematology
·
6
PDF
Retention of aggregated LDL by cultured human coronary artery endothelial cells
2004
·
Bin Zhao
, Wei Huang
, et al.
·
Biochemical and Biophysical Research Communications
·
5
Oxidized Low-Density Lipoprotein Inhibits the Binding of Monoclonal Antibody to Platelet Glycoprotein IIB-IIIA
1999
·
T Szuwart
, B Zhao
, et al.
·
Thrombosis Research
·
5
Abstract B24: Pharmacokinetic and pharmacodynamic profile of the novel, oral and selective CCR2 inhibitor CCX872-B in a Phase 1B pancreatic cancer trial
2015
·
Aram Hezel
, Ferry Eskens
, et al.
·
Molecular Cancer Therapeutics
·
1
Complement C5a Receptor in Macrophage-Mediated Renal Inflammation and Fibrosis in Lupus Nephritis
2021
·
Chris Li
, Bin N. Zhao
, et al.
·
Journal of the American Society of Nephrology
Therapeutic Benefit of CCR2 Antagonism in a Model of Diabetic Nephropathy Suggests a Mechanism of Action Distinct from Nrf2 Activation
2020
·
Zhenhua Miao
, Bin N. Zhao
, et al.
·
Journal of the American Society of Nephrology
P0336inhibition C-c Chemokine Receptor Type 2 (ccr2) on Activated Kidney Parietal Epithelial Cells Reveals a New Therapeutic Approach for Chronic Kidney Diseases
2020
·
Bin Zhao
, Zhenhua Miao
, et al.
·
Nephrology Dialysis Transplantation
PDF
P0973allosteric C-c Chemokine Receptor Type 2 (ccr2) Inhibition Improves Renal Function in a Murine Model of Diabetic Nephropathy
2020
·
Zhenhua Miao
, Linda S Ertl
, et al.
·
Nephrology Dialysis Transplantation
Fp240ccr2 Inhibition Improves Renal Function in Murine Models of Chronic Kidney Disease
2019
·
Zhenhua Miao
, Linda Ertl
, et al.
·
Nephrology Dialysis Transplantation
SaO058CCR2 INHIBITION IMPROVES RENAL FUNCTION & NORMALIZES GLOMERULAR STRUCTURE IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) MODELS
2018
·
Zhenhua Miao
, Linda Ertl
, et al.
·
Nephrology Dialysis Transplantation
PDF
To041ccr2 Antagonism Reduces Proteinuria and Glomerular Injury in Murine Models of Focal Segmental Glomerulosclerosis (fsgs)
2017
·
Zhenhua Miao
, Linda Ertl
, et al.
·
Nephrology Dialysis Transplantation
Show more works
View as search
Works count:
23
Citation count:
1,028
H-index:
11
I10-index:
12
Year
Topic
Type
